Diagnosis of SARS-CoV-2: Experience with rapid immunochromatography tests and RT‒qPCR

Background: Mexico has experienced six waves were experiences between 2019 and 2023 of coronavirus disease 2019 (COVID-19). In the first wave, diagnosis relied on RT‒qPCR; rapid tests for SARS‒CoV‒2 were introduced from the second wave onward. However, the patterns of results with this test in Mexic...

Full description

Saved in:
Bibliographic Details
Main Authors: David Alejandro Cabrera Gaytán, Porfirio Felipe Hernández Bautista, Clara Esperanza Santacruz Tinoco, Julio Elias Alvarado Yaah, Yu-Mei Anguiano Hernández, Bernardo Martínez Miguel, Alfonso Vallejos Parás, Lumumba Arriaga Nieto, Nancy Sandoval Gutiérrez, Concepción Grajales Muñiz, Alejandro Moctezuma Paz, Leticia Jaimes Betancourt
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Journal of Clinical Virology Plus
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667038025000067
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850160267979128832
author David Alejandro Cabrera Gaytán
Porfirio Felipe Hernández Bautista
Clara Esperanza Santacruz Tinoco
Julio Elias Alvarado Yaah
Yu-Mei Anguiano Hernández
Bernardo Martínez Miguel
Alfonso Vallejos Parás
Lumumba Arriaga Nieto
Nancy Sandoval Gutiérrez
Concepción Grajales Muñiz
Alejandro Moctezuma Paz
Leticia Jaimes Betancourt
author_facet David Alejandro Cabrera Gaytán
Porfirio Felipe Hernández Bautista
Clara Esperanza Santacruz Tinoco
Julio Elias Alvarado Yaah
Yu-Mei Anguiano Hernández
Bernardo Martínez Miguel
Alfonso Vallejos Parás
Lumumba Arriaga Nieto
Nancy Sandoval Gutiérrez
Concepción Grajales Muñiz
Alejandro Moctezuma Paz
Leticia Jaimes Betancourt
author_sort David Alejandro Cabrera Gaytán
collection DOAJ
description Background: Mexico has experienced six waves were experiences between 2019 and 2023 of coronavirus disease 2019 (COVID-19). In the first wave, diagnosis relied on RT‒qPCR; rapid tests for SARS‒CoV‒2 were introduced from the second wave onward. However, the patterns of results with this test in Mexico have not been documented in population-based studies. Objective: To describe the temporal patterns of the results from RT-qPCR and rapid immunochromatography tests for SARS-CoV-2 detection from the second to the sixth epidemic wave in Mexico. Materials and methods: This was a multicenter study at the national level. The operational definition of suspected cases of viral respiratory illness, confirmed cases of SARS-CoV-2 in Mexico, and data for asymptomatic individuals who required rapid testing between 2020 and 2023 were employed; testing was employed for the entirety of the four years. Positivity was estimated per epidemiological week, state, and condition for both tests. Spearman's correlation coefficient, trend chi-square analysis, and odds ratios with 95 % confidence intervals were used. Results: A total of 1749,765 cases had RT‒qPCR data recorded from 2020 to 2023, and 8356,903 cases with rapid tests were conducted for virus identification. Compared with the rest of the country, the southeastern region exhibited different patterns. The positivity rate of rapid tests from the epidemiological surveillance system was lower than that of RT‒qPCR during interepidemics periods, whereas the positivity rate of rapid tests for symptomatic individuals was higher than that of RT‒qPCR tests over two years. Conclusion: Rapid tests for SARS-CoV-2 identification in Mexico were affordable and timely at the local level. These tests revealed differing epidemic wave patterns in the southeastern region of the country.
format Article
id doaj-art-afcf047f724d468a89de9df03747abfb
institution OA Journals
issn 2667-0380
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Journal of Clinical Virology Plus
spelling doaj-art-afcf047f724d468a89de9df03747abfb2025-08-20T02:23:11ZengElsevierJournal of Clinical Virology Plus2667-03802025-06-015210020710.1016/j.jcvp.2025.100207Diagnosis of SARS-CoV-2: Experience with rapid immunochromatography tests and RT‒qPCRDavid Alejandro Cabrera Gaytán0Porfirio Felipe Hernández Bautista1Clara Esperanza Santacruz Tinoco2Julio Elias Alvarado Yaah3Yu-Mei Anguiano Hernández4Bernardo Martínez Miguel5Alfonso Vallejos Parás6Lumumba Arriaga Nieto7Nancy Sandoval Gutiérrez8Concepción Grajales Muñiz9Alejandro Moctezuma Paz10Leticia Jaimes Betancourt11Coordinación de Calidad de Insumos y Laboratorios Especializados. Instituto Mexicano del Seguro Social, Ciudad de México, México; Corresponding author.Coordinación de Calidad de Insumos y Laboratorios Especializados. Instituto Mexicano del Seguro Social, Ciudad de México, MéxicoCoordinación de Calidad de Insumos y Laboratorios Especializados. Instituto Mexicano del Seguro Social, Ciudad de México, MéxicoCoordinación de Calidad de Insumos y Laboratorios Especializados. Instituto Mexicano del Seguro Social, Ciudad de México, MéxicoCoordinación de Calidad de Insumos y Laboratorios Especializados. Instituto Mexicano del Seguro Social, Ciudad de México, MéxicoCoordinación de Calidad de Insumos y Laboratorios Especializados. Instituto Mexicano del Seguro Social, Ciudad de México, MéxicoCoordinación de Vigilancia Epidemiológica, Instituto Mexicano del Seguro Social, Ciudad de México, MéxicoCoordinación de Vigilancia Epidemiológica, Instituto Mexicano del Seguro Social, Ciudad de México, MéxicoCoordinación de Calidad de Insumos y Laboratorios Especializados. Instituto Mexicano del Seguro Social, Ciudad de México, MéxicoOrganismo Público Descentralizado Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), Ciudad de México, MéxicoCoordinación de Investigación en Salud, Instituto Mexicano del Seguro Social, Ciudad de México, MéxicoUnidad de Medicina Familiar No 7, Instituto Mexicano del Seguro Social, Ciudad de México, MéxicoBackground: Mexico has experienced six waves were experiences between 2019 and 2023 of coronavirus disease 2019 (COVID-19). In the first wave, diagnosis relied on RT‒qPCR; rapid tests for SARS‒CoV‒2 were introduced from the second wave onward. However, the patterns of results with this test in Mexico have not been documented in population-based studies. Objective: To describe the temporal patterns of the results from RT-qPCR and rapid immunochromatography tests for SARS-CoV-2 detection from the second to the sixth epidemic wave in Mexico. Materials and methods: This was a multicenter study at the national level. The operational definition of suspected cases of viral respiratory illness, confirmed cases of SARS-CoV-2 in Mexico, and data for asymptomatic individuals who required rapid testing between 2020 and 2023 were employed; testing was employed for the entirety of the four years. Positivity was estimated per epidemiological week, state, and condition for both tests. Spearman's correlation coefficient, trend chi-square analysis, and odds ratios with 95 % confidence intervals were used. Results: A total of 1749,765 cases had RT‒qPCR data recorded from 2020 to 2023, and 8356,903 cases with rapid tests were conducted for virus identification. Compared with the rest of the country, the southeastern region exhibited different patterns. The positivity rate of rapid tests from the epidemiological surveillance system was lower than that of RT‒qPCR during interepidemics periods, whereas the positivity rate of rapid tests for symptomatic individuals was higher than that of RT‒qPCR tests over two years. Conclusion: Rapid tests for SARS-CoV-2 identification in Mexico were affordable and timely at the local level. These tests revealed differing epidemic wave patterns in the southeastern region of the country.http://www.sciencedirect.com/science/article/pii/S2667038025000067RT‒qPCRSARS-CoV-2Rapid antigen testEpidemiological surveillanceRdRp gene
spellingShingle David Alejandro Cabrera Gaytán
Porfirio Felipe Hernández Bautista
Clara Esperanza Santacruz Tinoco
Julio Elias Alvarado Yaah
Yu-Mei Anguiano Hernández
Bernardo Martínez Miguel
Alfonso Vallejos Parás
Lumumba Arriaga Nieto
Nancy Sandoval Gutiérrez
Concepción Grajales Muñiz
Alejandro Moctezuma Paz
Leticia Jaimes Betancourt
Diagnosis of SARS-CoV-2: Experience with rapid immunochromatography tests and RT‒qPCR
Journal of Clinical Virology Plus
RT‒qPCR
SARS-CoV-2
Rapid antigen test
Epidemiological surveillance
RdRp gene
title Diagnosis of SARS-CoV-2: Experience with rapid immunochromatography tests and RT‒qPCR
title_full Diagnosis of SARS-CoV-2: Experience with rapid immunochromatography tests and RT‒qPCR
title_fullStr Diagnosis of SARS-CoV-2: Experience with rapid immunochromatography tests and RT‒qPCR
title_full_unstemmed Diagnosis of SARS-CoV-2: Experience with rapid immunochromatography tests and RT‒qPCR
title_short Diagnosis of SARS-CoV-2: Experience with rapid immunochromatography tests and RT‒qPCR
title_sort diagnosis of sars cov 2 experience with rapid immunochromatography tests and rt qpcr
topic RT‒qPCR
SARS-CoV-2
Rapid antigen test
Epidemiological surveillance
RdRp gene
url http://www.sciencedirect.com/science/article/pii/S2667038025000067
work_keys_str_mv AT davidalejandrocabreragaytan diagnosisofsarscov2experiencewithrapidimmunochromatographytestsandrtqpcr
AT porfiriofelipehernandezbautista diagnosisofsarscov2experiencewithrapidimmunochromatographytestsandrtqpcr
AT claraesperanzasantacruztinoco diagnosisofsarscov2experiencewithrapidimmunochromatographytestsandrtqpcr
AT julioeliasalvaradoyaah diagnosisofsarscov2experiencewithrapidimmunochromatographytestsandrtqpcr
AT yumeianguianohernandez diagnosisofsarscov2experiencewithrapidimmunochromatographytestsandrtqpcr
AT bernardomartinezmiguel diagnosisofsarscov2experiencewithrapidimmunochromatographytestsandrtqpcr
AT alfonsovallejosparas diagnosisofsarscov2experiencewithrapidimmunochromatographytestsandrtqpcr
AT lumumbaarriaganieto diagnosisofsarscov2experiencewithrapidimmunochromatographytestsandrtqpcr
AT nancysandovalgutierrez diagnosisofsarscov2experiencewithrapidimmunochromatographytestsandrtqpcr
AT concepciongrajalesmuniz diagnosisofsarscov2experiencewithrapidimmunochromatographytestsandrtqpcr
AT alejandromoctezumapaz diagnosisofsarscov2experiencewithrapidimmunochromatographytestsandrtqpcr
AT leticiajaimesbetancourt diagnosisofsarscov2experiencewithrapidimmunochromatographytestsandrtqpcr